Purchases and Sales Made in Q2 2023 in Diffusion Pharmaceuticals Inc. (DFFN)
This table provides information about the institutional ownership of Diffusion Pharmaceuticals Inc. (DFFN) during Q2 2023. The information is specifically focused on institutions that hold shares of Diffusion Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
1.2K+ 3.07% |
$4.01K - $5.64K
|
40.3K
$373K
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 7.14% |
$3.34 - $4.7
|
15
$139
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 10, 2023
Q2 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-20- 3.26% |
$66.8 - $94
|
594
$5.49K
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-410- 87.23% |
$1.37K - $1.93K
|
60
$555
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-910- 27.41% |
$3.04K - $4.28K
|
2.41K
$22.3K
|
|
|
Aug 14, 2023
Q2 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-6.53K- 8.98% |
$21.8K - $30.7K
|
66.2K
$613K
|